Main > INFECTIOUS DISEASES > Virus Infectious Diseases+ > HIV Infection (AIDS) > LipoDystrophy [Abdominal Fat (VAT)] > Treatment > Co: CA. T. Tesamorelin For Inj.
Co: CA. T. Tesamorelin For Inj.'s subsections
(*) CA Approval Date: 2015. 03.30.
(*) MX Approval Date: 2015. 07.14.
(*) USA Approval Date: 2010. 11.11.
Company
GHRF Analog
Licensees:
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2017. 04.11.
Patent>USA Expiration: 2020. 05.
TradeMark
TradeMark Web-Site
Co: CA. T. Tesamorelin For Inj.'s products
This section has no products